Get started
Dynavax Technologies CorporationDynavax Technologies CorporationDynavax Technologies Corporation

Dynavax Technologies Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

DVAX chart


Full chart

DVAX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.58 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
89.72
Basic EPS (TTM)
0.16 USD
Net income (FY)
‪−6.39 M‬ USD
Revenue (FY)
‪232.28 M‬ USD
Shares float
‪130.91 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
408
Change (1Y)
+57 +16.24%
Revenue / Employee (1Y)
‪569.32 K‬ USD
Net income / Employee (1Y)
‪−15.66 K‬ USD

About Dynavax Technologies Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Ryan Spencer
Website
dynavax.com
Headquarters
Emeryville
Founded
1996
FIGI
BBG000BFX694
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

DVAX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

DVAX highest yielding bonds


DVAX5420600
Dynavax Technologies Corporation 2.5% 15-MAY-2026
Yield to maturity
−14.91%
Maturity date
May 15, 2026

Explore more bonds 

Frequently Asked Questions


The current price of DVAX is 12.17 USD — it has increased by 2.74% in the past 24 hours. Watch Dynavax Technologies Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dynavax Technologies Corporation stocks are traded under the ticker DVAX.
DVAX stock has fallen by −11.04% compared to the previous week, the month change is a 9.58% rise, over the last year Dynavax Technologies Corporation has showed a −10.32% decrease.
We've gathered analysts' opinions on Dynavax Technologies Corporation future price: according to them, DVAX price has a max estimate of 29.00 USD and a min estimate of 15.00 USD. Watch DVAX chart and read a more detailed Dynavax Technologies Corporation stock forecast: see what analysts think of Dynavax Technologies Corporation and suggest that you do with its stocks.
DVAX reached its all-time high on Nov 29, 2006 with the price of 106.60 USD, and its all-time low was 1.50 USD and was reached on Nov 20, 2008. View more price dynamics on DVAX chart.
See other stocks reaching their highest and lowest prices.
DVAX stock is 4.13% volatile and has beta coefficient of 0.37. Track Dynavax Technologies Corporation stock price on the chart and check out the list of the most volatile stocks — is Dynavax Technologies Corporation there?
Today Dynavax Technologies Corporation has the market capitalization of ‪1.58 B‬, it has increased by 9.85% over the last week.
Yes, you can track Dynavax Technologies Corporation financials in yearly and quarterly reports right on TradingView.
Dynavax Technologies Corporation is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
DVAX earnings for the last quarter are 0.12 USD per share, whereas the estimation was 0.11 USD resulting in a 5.89% surprise. The estimated earnings for the next quarter are 0.04 USD per share. See more details about Dynavax Technologies Corporation earnings.
Dynavax Technologies Corporation revenue for the last quarter amounts to ‪80.63 M‬ USD, despite the estimated figure of ‪84.17 M‬ USD. In the next quarter, revenue is expected to reach ‪71.71 M‬ USD.
DVAX net income for the last quarter is ‪17.59 M‬ USD, while the quarter before that showed ‪11.39 M‬ USD of net income which accounts for 54.52% change. Track more Dynavax Technologies Corporation financial stats to get the full picture.
No, DVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 408.00 employees. See our rating of the largest employees — is Dynavax Technologies Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dynavax Technologies Corporation EBITDA is ‪496.00 K‬ USD, and current EBITDA margin is −11.53%. See more stats in Dynavax Technologies Corporation financial statements.
Like other stocks, DVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dynavax Technologies Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dynavax Technologies Corporation technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dynavax Technologies Corporation stock shows the buy signal. See more of Dynavax Technologies Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.